Boston Medical Center — Boston, Massachusetts

Public research footprint of Boston Medical Center, compiled from the ClinicalTrials.gov public registry.

1,077

Registered studies

259

Active

123

Recruiting now

650

Completed

146

Stopped or withdrawn

Most-studied conditions

Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Recurrent Melanoma · Stage IV Cutaneous Melanoma AJCC v6 and v7 · Recurrent Neck Squamous Cell Carcinoma of Unknown Primary

Recently updated registry entries

NCT02196181 — Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer… (Active Not Recruiting)
NCT06589804 — Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment… (Recruiting)
NCT04847453 — Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Boston Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.